SOLVAY S.A. A/ BE0003470755 /
08/07/2024 16:49:27 | Chg. +0.320 | Volume | Bid16:49:27 | Ask16:49:27 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
33.790EUR | +0.96% | - Turnover: - |
33.790Bid Size: - | 33.800Ask Size: - | 3.54 bill.EUR | 7.21% | 1.68 |
GlobeNewswire
25/10/2023
NobleAI Announces Groundbreaking Collaboration with Microsoft Azure Quantum Elements
GlobeNewswire
12/10/2023
NobleAI’s Science-Based AI Technology to be Highlighted at SPE Annual Technical Conference and Expos...
GlobeNewswire
07/10/2023
CERN Inaugurates Science Gateway, Its New Outreach Centre for Science Education
GlobeNewswire
19/09/2023
Radix Engineering Expands US Operations, Appoints Alexander Clausbruch North America CEO
GlobeNewswire
07/09/2023
NobleAI Launches New AI-Powered Chemical and Materials Informatics Solutions on Microsoft’s Azure Ma...
GlobeNewswire
17/02/2022
Bluebell Capital Partners - Response to Solvay Board Open Letter Regarding Soda Ash Operations in Ro...
GlobeNewswire
11/01/2022
Western Rare Earths Announced as Team Member of the US Critical Materials Institute; Partner to DOE ...
GlobeNewswire
29/03/2021
Solvay’s Kadri will Present Keynote Lecture at AIChE’s Virtual Spring Meeting & Global Congress on P...
GlobeNewswire
01/10/2020
Intra-Cellular Therapies Announces the Appointment of Dr. Suresh Durgam as Chief Medical Officer